Assured Pharmacy, Inc. (APHY.OB) operates pharmacies that provide prescription pain medications for chronic pain management to patients and physicians in the United States. The company is planning an aggressive new store opening campaign for 2013, which has to lead to a national foot print over the next 3 years. The company is still a small loss-making specialty pharmacy that will face the hurdles that belongs to expansion. Despite that it can take a piece of the cake and become a serious nationwide player.
The company's business model targets physicians specializing in pain management - orthopedics, neurology, oncology, psychiatry, physical rehabilitation and industrial medicine. The focus is on treating patients with long-term, acute, chronic pain conditions. Assured Pharmacy generates its revenue principally from the sale of Schedule II and III prescription pain relievers.
Assured Pharmacy market cap is around $5 million and float is practically non-existent, when considering the preferred shares outstanding the real market capitalization of the company is closer to 23 million. This stock would I would recommend for risk-seeking investors looking to hold shares for at least several years.